Versatile cationic lipids for siRNA delivery-Reference-Cited by-同舟云学术

Versatile cationic lipids for siRNA delivery

Published:2012-03 Issue:2 Volume:158 Page:269-276
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Sparks Jeff,Slobodkin Gregory,Matar Majed,Congo Richard,Ulkoski David,Rea-Ramsey Angela,Pence Casey,Rice Jennifer,McClure Diane,Polach Kevin J.,Brunhoeber Elaine,Wilkinson Leslie,Wallace Kirby,Anwer Khursheed,Fewell Jason G.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference32 articles.

1. Biological barriers to therapy with antisense and siRNA oligonucleotides;Juliano;Mol. Pharm.,2009

2. Knocking down barriers: advances in siRNA delivery;Whitehead;Nat. Rev. Drug Discov.,2009

3. Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates;Frank-Kamenetsky;Proc. Natl. Acad. Sci. U. S. A.,2008

4. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study;Geisbert;Lancet,2010

5. RNAi-mediated gene silencing in non-human primates;Zimmermann;Nature,2006

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delivery of miRNAs Using Nanoparticles for the Treatment of Osteosarcoma;International Journal of Nanomedicine;2024-08

2. Liposomal nanocarriers containing siRNA as small molecule-based drugs to overcome cancer drug resistance;Nanomedicine;2023-11-15

3. A cationic cyclodextrin derivative-lipid hybrid nanoparticles for gene delivery effectively promotes stability and transfection efficiency;Drug Development and Industrial Pharmacy;2022-01-02

4. Lipophilic Polyamines as Promising Components of Liposomal Gene Delivery Systems;Pharmaceutics;2021-06-21

5. Nucleic acids delivered by PEGylated cationic liposomes in systemic lupus erythematosus-prone mice: A possible exacerbation of lupus nephritis in the presence of pre-existing anti-nucleic acid antibodies;International Journal of Pharmaceutics;2021-05